A local technical college that went under after years of financial struggles, could be coming back to life under a new name ...

PTC Therapeutics’ amyotrophic lateral sclerosis (ALS) prospect has flunked a phase 2 trial, prompting the biotech to drop plans for further development of the drug candidate. The study ...

PTC PTC has outperformed the market over the past 5 years by 8.6% on an annualized basis producing an average annual return of 22.31%. Currently, PTC has a market capitalization of $24.23 billion ...

PTC Therapeutics may be reeling from the failure of its amyotrophic lateral sclerosis (ALS) drug utreloxastat yesterday, but the biotech can console itself by counting the cash from the sale of ...

"The board met on December 13, wherein the contents of SAT's order dated December 11 were noted. The board resolved that ...

New Delhi, Dec 12 (PTI) The Securities Appellate Tribunal (SAT) has quashed a Sebi order that restrained former PTC India ...

PTC Therapeutic's Upstaza gene therapy for patients with genetic disorder AADC deficiency has been recommended for approval in the EU, setting up another test of the commercial prospects for ...

Analysts have been eager to weigh in on the Technology sector with new ratings on Akamai (AKAM – Research Report) and PTC (PTC – Research Report). Akamai (AKAM) Akamai received a Hold rating ...

MUNICH--(BUSINESS WIRE)--SimScale, the leading provider of cloud-native engineering simulation software, is thrilled to announce a strategic collaboration with PTC and its Onshape® solution ...